Acute immunologic effects of interleukin-2 therapy in cancer patients: decreased delayed type hypersensitivity response and decreased proliferative response to soluble antigens.

Source:http://linkedlifedata.com/resource/pubmed/id/3262151

Download in:

View as

General Info

PMID
3262151